Psychiatric Issues in LTC: Antipsychotic Use Reduction

This program will present the tools necessary for implementing a successful antipsychotic reduction program. Non-pharmacological interventions are the mainstay of therapy, and a strategy of staff and family education, along with a willingness to try multiple non-pharmacological approaches in an attempt to personalize therapy, are the foundation of a successful antipsychotic reduction program. 


Jay Luxenberg, MD

Learning Objectives:

  • Review the evidence for efficacy of non-pharmacological management of behavioral and psychological symptoms of dementia (BPSD).
  • Compare the data for efficacy of antipsychotics with the evidence for harm to allow an appropriate risk benefit analysis.
  • Explore the alternatives to antipsychotics for BPSD management, again comparing efficacy data with harm.


1.5 CME, 1.5 CMD clinical
CME/CMD credits available until April 2017.

Member Non-Member